A comprehensive evaluation, including symptoms, medical history, C-peptide levels, and anti-GAD antibodies, is essential for distinguishing between diabetes' types, particularly in cases of diagnostic uncertainty. While obesity is often associated with T2DM, BMI should be viewed as a factor rather than a criterion for the exclusion of diabetes type.
Keywords: c‐peptide; misdiagnosis; obesity; type 1 diabetes mellitus.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.